Valuation: JMS Co.,Ltd.

Market Cap 10.79B 68.78M 61.41M 56.75M 51.45M 96.31M 6.53B 97.81M 678M 270M 3.42B 258M 253M P/E 2025
127x
P/E 2026 -13.3x
Enterprise Value 31.08B 198M 177M 163M 148M 277M 18.81B 282M 1.95B 777M 9.85B 744M 728M EV / Sales 2025
0.43x
EV / Sales 2026 0.47x
Free-Float
64%
Yield 2025
3.69%
Yield 2026 4%
05-12 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Half Year Ending September 2026 and the Full Year Ending March 31, 2027 CI
05-12 JMS Co.,Ltd. Proposes Dividend for Fiscal Year Ended March 31, 2026, Payable on June 24, 2026; Provides Dividend Guidance for Second Quarter Ending September 2026 and Fiscal Year Ending March 31, 2027 CI
02-06 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026 CI
11-07 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 CI
11-07 JMS Co.,Ltd. Announces Dividend for the Second Quarter End of the Fiscal Year Ending March 31, 2026, Payable on December 10, 2025 CI
25-05-09 JMS Co.,Ltd. Announces Dividend for the Year Ended March 31, 2025, Payable on June 25, 2025; Provides Dividend Guidance for the Second Quarter and Year Ending March 31, 2026 CI
25-05-09 JMS Co.,Ltd. Provides Earnings Guidance for the Six Months Ending September 2025 and the Full Year Ending March 31, 2026 CI
25-02-07 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025 CI
24-11-07 JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025 CI
24-11-07 JMS Co.,Ltd. Announces Dividend for the Second Quarter Period Ended September 2024, Payable on December 10, 2024 and Provides Dividend Guidance for the Year Ending March 31, 2025 CI
24-05-14 JMS Co.,Ltd. Provides Earnings Guidance for the Six Months Ending September 2024 and the Full Year Ending March 31, 2025 CI
24-05-14 Jms Co.,Ltd. Announces Dividend for the Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the Second Quarter Ending September 2024 and Year Ending March 31, 2025 CI
23-11-07 JMS Co.,Ltd. Announces Dividend for the Second Quarter ended September 2023 Payable on December 8, 2023; Provides Guidance for the Year End for the Year March 31, 2024 CI
1 day-2.00%
1 week-0.68%
Current month-3.08%
1 month-4.14%
3 months-5.98%
6 months+1.85%
Current year-0.45%
1 week 439
Extreme 439
454
1 month 439
Extreme 439
463
Current year 418
Extreme 418
478
1 year 418
Extreme 418
478
3 years 405
Extreme 405
549
5 years 405
Extreme 405
778
10 years 405
Extreme 405
1,198
Manager TitleAgeSince
Director of Finance/CFO 63 2007-06-30
Chief Tech/Sci/R&D Officer 59 2023-05-31
Corporate Officer/Principal 59 2012-03-31
Director TitleAgeSince
Chairman 71 2024-05-31
Director/Board Member 65 2011-05-31
Director/Board Member 70 2023-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-0.68%-1.12%-16.35% 70.06M
+1.16%-0.94%-18.95%+7.15% 177B
-1.22%-0.04%-0.51%+31.24% 118B
+0.02%+4.75%-20.91%+15.60% 118B
+2.29%+21.86%-41.81%+11.12% 91.21B
-2.21%-3.05%+0.06%+75.36% 64.59B
-1.06%+4.59%+13.36%+78.58% 56.13B
-0.75%+2.66%+5.74%-23.09% 54.59B
-1.13%+2.41%-11.58%+31.24% 43.6B
+0.17%+5.12%-4.89%-10.48% 33.95B
Average -0.47%+3.93%-8.06%+20.04% 75.76B
Weighted average by Cap. -0.02%+3.55%-12.28%+22.23%

Financials

2025 2026
Net sales 69.75B 444M 397M 367M 332M 622M 42.2B 632M 4.38B 1.74B 22.1B 1.67B 1.63B 65.84B 420M 375M 346M 314M 588M 39.84B 597M 4.14B 1.65B 20.86B 1.58B 1.54B
Net income 89M 567K 506K 468K 424K 794K 53.85M 807K 5.59M 2.22M 28.19M 2.13M 2.08M -783M -4.99M -4.46M -4.12M -3.73M -6.99M -474M -7.1M -49.18M -19.57M -248M -18.73M -18.34M
Net Debt 19.04B 121M 108M 100M 90.76M 170M 11.52B 173M 1.2B 476M 6.03B 456M 446M 20.28B 129M 115M 107M 96.7M 181M 12.27B 184M 1.27B 507M 6.43B 485M 475M
Projected Income Statement - Annual - JMS Co.,Ltd.
Logo JMS Co.,Ltd.
JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Company’s main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.
Employees
4,887
Date Price Change Volume
26-10-23 JP¥440.00 -2.00% 36,600
26-10-22 JP¥449.00 -0.66% 17,300
26-10-21 JP¥452.00 -0.22% 21,100
26-10-20 JP¥453.00 +1.57% 40,700
26-10-19 JP¥446.00 -0.67% 46,000

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - JMS Co.,Ltd.
  1. Stock Market
  2. Stocks
  3. 7702 Stock